검색어: depreotidi (핀란드어 - 영어)

depreotidi
depreotide

tc- depreotidi
(see section 4.3) when it is necessary to administer radioactive medicinal products to women of childbearing potential,

neospectin vaikuttava aine on depreotidi.
neospect includes a white powder for solution for injection, which contains the active substance depreotide.

neospectin vaikuttava aine, depreotidi, on somatostatiinianalogi.
the active substance in neospect, depreotide, is a somatostatin analogue.

99m tc- depreotidi annetaan laskimonsisäisenä kerta- annoksena.
99m tc-depreotide is administered intravenously in a single dose.

neospect 47 mikrogrammaa, valmisteyhdistelmä radioaktiivista lääkettä varten depreotidi
neospect 47 micrograms, kit for radiopharmaceutical preparation depreotide

neospect 47 mikrogrammaa, valmisteyhdistelmä radioaktiivista lääkettä varten depreotidi laskimoon
neospect 47 micrograms, kit for radiopharmaceutical preparation depreotide intravenous use

tutkimuksissa saadun tiedon mukaan 99mtc-depreotidi sitoutuu lujasti somatostatiinireseptoreihin.
the data indicate that the 99mtc-depreotide displays high-affinity binding to somatostatin receptors.

mahdollisesti kehoosi jäävä 99mtc-depreotidi menettää radioaktiivisuutensa 2-3 vuorokaudessa.
any 99mtc-depreotide which remains in your body, will naturally lose its radioactivity within 2-3 days.

siihen sisältyy valkoinen injektiokuiva-aine liuosta varten.neospectin vaikuttava aine on depreotidi.
neospect includes a white powder for solution for injection, which contains the active substance depreotide.

99mtc-depreotidi on siten kontraindisoitu raskauden aikana (kts kohta 4.3).
99mtc-depreotide is therefore contraindicated in pregnancy. (see section 4.3)

natrium perteknetaatti-injektionesteellä (99mtc) rekonstituoinnin jälkeen muodostuu 99mtc-depreotidi.
after reconstitution with sodium pertechnetate (99mtc) solution for injection, 99mtc-depreotide is formed.

neospectin sisältö on tarkoitettu ainoastaan 99mtc-depreotidi-injektionnesteen valmistamiseen (katso kohta 12).
the contents of neospect are intended only for use in the preparation of 99mtc-depreotide solution for injection (see section 12).

kun neospect radioleimataan, radioaktiivinen yhdiste teknetium-99m (99mtc) kiinnittyy depreotidiin.
when neospect is radiolabelled, the radioactive element technetium-99m (99mtc) is attached to depreotide.